Cue Biopharma, Inc.

NASDAQ:CUE

0.82 (USD) • At close July 29, 2025
Bedrijfsnaam Cue Biopharma, Inc.
Symbool CUE
Munteenheid USD
Prijs 0.82
Beurswaarde 61,809,523
Dividendpercentage 0%
52-weken bereik 0.45 - 1.989
Industrie Biotechnology
Sector Healthcare
CEO Mr. Daniel R. Passeri J.D., M.Sc., MSc.
Website https://www.cuebiopharma.com

An error occurred while fetching data.

Over Cue Biopharma, Inc.

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to

Vergelijkbare Aandelen

Gamida Cell Ltd. logo

Gamida Cell Ltd.

GMDA

0.033 USD

CorMedix Inc. logo

CorMedix Inc.

CRMD

11.64 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.032 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

11.04 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.96 USD

Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

OVID

0.54 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)